Sunstone Life Science Ventures

Venture Capital Capital Region of Denmark, Denmark ·Founded 2007

Overview

Sunstone Life Science Ventures is an independent European venture capital firm founded in 2007, focusing on developing and expanding early-stage life science companies with strong potential to achieve global success. The firm manages approximately €500 million in assets and has invested in over 45 companies across pharmaceuticals, medical technologies, and diagnostics, achieving more than 20 successful IPOs and large M&A transactions. The firm's investment strategy centers on novel therapeutics with the potential to improve patient care and treatment. Sunstone typically invests in companies raising Series A or B rounds, emphasizing strong scientific rationale and attractive business cases. Geographically, the firm focuses on Europe, particularly large life science hubs, and has made investments in Denmark, Finland, Germany, Sweden, the United Kingdom, and the United States. Sunstone's team comprises industry experts with combined entrepreneurial, operational, and financial experience. They provide comprehensive support to portfolio companies, including strategic guidance, operational optimization, regulatory navigation, and market access planning. This hands-on approach has established Sunstone as a value-added partner for emerging biotech companies navigating the complex path from discovery to commercialization.

Investment Focus

  • Focus on novel therapeutics
  • Strong potential for global success
  • Early-stage companies
  • European market emphasis
  • Strong scientific rationale
  • Attractive business case
  • Potential for global success
  • Focus on early-stage life science companies

Portfolio Companies

CortiForendo PharmaSynendos TherapeuticsSTipe TherapeuticsRigontecPrexton TherapeuticsArcoma ABIO BiotechOxTheraAntargiaAdenium BiotechMinervaxGalecto BiotechAlligator BiosciencesZeal & Revolutionary Health SolutionsVaximmOrphazymeAscella PharmaNuevolutionSymphogenEvolvaResalis TherapeuticsTeitur TrophicsRewind Therapeutics

Get the full list of 54,000+ investors

Sunstone Life Science Ventures and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Sunstone Life Science Ventures

What sectors does Sunstone Life Science Ventures invest in?

Sunstone Life Science Ventures invests in Healthcare, Life Sciences, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Capital Region of Denmark, Denmark. Sunstone Life Science Ventures is listed as a venture capital in the ConnectSafely investor database.

What stage does Sunstone Life Science Ventures invest at?

Sunstone Life Science Ventures backs companies at Seed, Early Stage, Series A, Series B and Growth, writing cheques of 1.5M - 3M.

Which regions does Sunstone Life Science Ventures invest in?

Sunstone Life Science Ventures invests across United States, United Kingdom, Germany, France, Italy and Denmark.

What companies has Sunstone Life Science Ventures invested in?

Sunstone Life Science Ventures's portfolio includes Corti, Forendo Pharma, Synendos Therapeutics, STipe Therapeutics, Rigontec, Prexton Therapeutics, Arcoma AB and IO Biotech.

Last updated · Source: ConnectSafely investor database